text.skipToContent text.skipToNavigation

Maximum quantity allowed is 999

Please select the quantity

CAS RN: 609799-22-6 | Product Number: T3813

Tasimelteon


Purity: >98.0%(HPLC)
Synonyms:
  • N-[[(1R,2R)-2-(2,3-Dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide
Product Documents:
10MG
$111.00
Contact Us Contact Us 7  
50MG
$333.00
Contact Us Contact Us 6  

* Items in stock locally ship in 1-2 business days. Items from Japan stock are able to ship from a US warehouse within 2 weeks. Please contact TCI for lead times on items not in stock. Excludes regulated items and items that ship on ice.
* To send your quote request for bulk quantities, please click on the "Request Quote" button. Please note that we cannot offer bulk quantities for some products.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.


Product Number T3813
Purity / Analysis Method >98.0%(HPLC)
Molecular Formula / Molecular Weight C__1__5H__1__9NO__2 = 245.32 
Physical State (20 deg.C) Solid
Storage Temperature Refrigerated (0-10°C)
Condition to Avoid Heat Sensitive
CAS RN 609799-22-6
Reaxys Registry Number 15439325
PubChem Substance ID 468592958
MDL Number

MFCD09033789

Specifications
Appearance White to Almost white powder to crystal
Purity(HPLC) min. 98.0 area%
Elemental analysis(Nitrogen) 5.30 to 6.10 %
Specific rotation [a]20/D -41.0 to -46.0 deg(C=1, CHCL3)
NMR confirm to structure
Properties (reference)
Melting Point 78 °C
Specific Rotation -45° (C=1,CHCl3)
GHS
Related Laws:
RTECS# TX1450577
Transport Information:
HS Number 2937.90.9000
Application
Tasimelteon: A Selective Melatonin MT1 and MT2 Receptors Agonist

Tasimelteon (BMS-214778) is a melatonin [M1105] receptor agonist with both high affinity for melatonin MT1 and MT2 receptors, similar to other members of the melatonin receptor agonist including ramelteon [R0216] and agomelatine [A2606]. Characteristically, tasimelteon exhibits a greater affinity for the MT2 as compared to the MT1 receptor. The agonist activity at the MT1 and MT2 receptors has been reported to contribute to its sleep-promoting properties. And then, tasimelteon currently is approved in the United States and the EU for the treatment of the treatment of non-24-hour sleep-wake disorder. (The product is for research purpose only.)

References


TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.

The requested SDS is not available.

Please Contact Us for more information.

Specifications
C of A & Other Certificates
Please enter Lot Number Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.

The product with the lot number searched for has been discontinued and no related documentation is available.

Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.

A sample C of A for this product is not available at this time.

Analytical Charts
Please enter Lot Number Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.

The requested analytical chart is not available. Sorry for the inconvenience.

The product with the lot number searched for has been discontinued and no related documentation is available.

Other Documents

Session Status
Your session will timeout in 10 minutes. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page. minute. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page.

Your session has timed out. You will be redirected to the HOME page.